Physician

Internal Medicine

Dr. Lynne E. Kallenbach, MD


Lynne E. Kallenbach practices Internal Medicine. She went to University of Kansas School of Medicine. She received awards:"CMS Meaningful Use Stage 1 Certification". Lynne E. Kallenbach, MD is also a published MD. She has 2 publication published. The most recent publication is: Predictors of long-acting opioid use and oral versus transdermal route among older Medicaid beneficiaries. Lynne Kallenbach accepts Medicare payments and is registered with Medicare.gov.



Publications


Schools


Conditions Treated


Doctors Specialties


Accepted Insurances


Awards


Education


Drug Facts


NPI NUMBER   1477655785
NPPES Provider LastName   KALLENBACH
NPPES Provider FirstName   LYNNE
NPPES Provider ZIPCode   662092503
NPPES Provider State   KS
Specialty Description   Hospice and Palliative Care
Total Claim Count   6763.0
Distinct Opioid Count   3.0
Opioid Claim Count   202.0
Percent Opioid Claims   2.99

Helpful Reviews


Give Anonymous Review


Medicare Facts


National Provider Identifier [NPI] 1477655785
Last Name Of The Provider KALLENBACH
First Name Of The Provider LYNNE
View All

Similar Doctors


Dr. Charles M. Stiles, MD
This Doctor is OpenDoctor Recommended.
Dr. Jennifer K. Johnson, MD
Dr. Charles W. Ragland, MD
This Doctor is OpenDoctor Recommended.
Dr. Bharata Lankachandra, MD
Dr. Charles I. Davis Jr., MD
This Doctor is OpenDoctor Recommended.
Dr. Austin T. Welsh, MD
This Doctor is OpenDoctor Recommended.
Dr. Andrew K. Karu, MD
This Doctor is OpenDoctor Recommended.
Dr. Sally K. Rigler, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Ryan E. McNellis, MD
This Doctor is OpenDoctor Recommended.
Dr. Kathleen R. Sproules, DO
Dr. Thomas H. Simmons, MD
This Doctor is OpenDoctor Recommended.
Dr. Mary Ann Lillig, DO
This Doctor is OpenDoctor Recommended.
Dr. Joyce Y. Hwang, MD
This Doctor is OpenDoctor Recommended.
Bakul V. Sangani, MB CHB
This Doctor is OpenDoctor Recommended.
Dr. Debashree Tosh, MD


Doctor Directory | TOS | twitter | FB | Angel | blog